GGrantIndex
Sort

40,608 grants matching prostate cancer

Mechanisms of pathogenesis in patient derived organoid models of prostate cancer

$1,177,606
Kathleen Kelly · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

TARGETING A KEY TUMOR PLASTICITY DRIVER IN LETHAL PROSTATE CANCER.

$1,177,500
University Of California, Davis · · FY2021 · Department of the Army

UNDERSTANDING THE ROLE OF P53 IN THE DEVELOPMENT AND PROGRESSION OF OLIGOMETASTATIC CASTRATION-SENSITIVE PROSTATE CANCER

$1,177,437
Rutgers The State University Of New Jersey · · FY2022 · Defense Health Agency

TARGETING PROSTATE CANCER STEMLIKE CELLS THROUGH CELL SURFACE-EXPRESSED GRP78

$1,177,372
Duke University · · FY2012 · Department of Defense

MATCHES: Making Telehealth Delivery of Cancer Care at Home Effective and Safe

$1,177,039
Katherine S Panageas · Sloan-Kettering Inst Can Research · P50 · FY2024 · CA

GENETIC EPIDEMIOLOGY OF LUNG CANCER

$1,175,837
University Of Cincinnati · U01 · FY2001 · CA

National Black Leadership Initiative on Cancer III

$1,175,511
David Satcher · Morehouse School Of Medicine · U01 · FY2006 · CA

Early clinial trials for Angelica herbal supplements for prostate cancer interception

$1,175,356
Junxuan Lu · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2025 · CA

National Black Leadership Initiative on Cancer III: Community Network

$1,174,945
David Satcher · Morehouse School Of Medicine · U01 · FY2007 · CA

REDUCTION OF LETHAL PROSTATE CANCER DISPARITIES IN UNDERSERVED HISPANIC/LATINO POPULATIONS

$1,174,652
Ponce Medical School Foundation Inc · · FY2021 · Defense Health Agency

APOPTOSIS INDUCTION BY TARGETING INTERFERON GAMMA RECEPTOR 2 (IFNGAMMAR2) IN PROSTATE CANCER: LIGAND (IFNGAMMA) INDEPENDENT NOVEL FUNCTION OF IFNGAMM

$1,174,400
Case Western Reserve University · · FY2012 · Department of Defense

Vaccine Clinical Trials

$1,173,524
Philip M Arlen · Basic Sciences · Z01 · FY2007 · CA

Vaccine Clinical Trials

$1,173,524
James L. Gulley · Basic Sciences · Z01 · FY2007 · CA

THERAPEUTIC TARGETING OF B7-H3 TO REVERSE PROSTATE CANCER TREATMENT RESISTANCE

$1,172,828
Duke University · · FY2016 · Department of the Army

MAPPING INTERACTIVE CANCER SUSCEPTIBILITY LOCI

$1,172,767
City Of Hope/Beckman Research Institute · R01 · FY2000 · AG

MECHANISMS OF REACTIVE STROMA-INDUCED TUMORIGENESIS IN PROSTATE CANCER

$1,171,996
Baylor College Of Medicine · · FY2012 · Department of the Army

National Black Leadership Initiative on Cancer III: Community Network

$1,171,704
Daniel Blumenthal · Morehouse School Of Medicine · U01 · FY2008 · CA

MAKING THE PROBLEM GO AWAY: TARGETING THE AR FOR DEGRADATION IN PROSTATE CANCER CELLS

$1,171,060
Yale Univ · · FY2012 · Department of the Army

Genetic Epidemiology of Cancer

$1,170,631
Joan E. Bailey-Wilson · National Human Genome Research Institute · ZIA · FY2022 · HG

3/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership

$1,170,535
Upender Manne · University Of Alabama At Birmingham · U54 · FY2017 · CA

3/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership

$1,170,535
Upender Manne · University Of Alabama At Birmingham · U54 · FY2018 · CA

Development and Validation of Artificial Intelligence Algorithms in Digital Pathology

$1,170,506
Stephanie Harmon · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

INTERACTION BETWEEN THE INFLAMMATORY MICROENVIRONMENT AND SOMATIC GENOMIC ALTERATIONS AS A DRIVER OF PROSTATE CANCER AGGRESSIVENESS IN AFRICAN MEN

$1,170,290
The Johns Hopkins University · · FY2017 · Department of the Army

Novel Targets for Immunotherapy

$1,170,238
Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA

Plant-based diets and risk of cancer

$1,170,084
Gary E. Fraser · Loma Linda University · U01 · FY2014 · CA